stella
beta
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 — Stella
Home
/
Charcot-Marie-Tooth Disease, Type Ia (Disorder)
/
View on ClinicalTrials.gov
Recruiting
Back to Charcot-Marie-Tooth Disease, Type Ia (Disorder) trials
Trial locations
(22 sites)
United States
Cedars-Sinai Medical Center, Los Angeles, California
Stanford University, Palo Alto, California
University of Colorado Hospital, Aurora, Colorado
Connecticut Children's Medical Center, Hartford, Connecticut
University of Miami, Miami, Florida
University of Iowa, Iowa City, Iowa
Johns Hopkins University, Baltimore, Maryland
Harvard/Massachusetts General Hospital, Boston, Massachusetts
University of Michigan, Ann Arbor, Michigan
University of Minnesota, Maple Grove, Minnesota
University of Rochester, Rochester, New York
University of North Carolina, Chapel Hill, North Carolina
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania
St. Jude Children's Research Hospital, Memphis, Tennessee
Houston Methodist Hospital, Houston, Texas
Seattle Children's Hospital, Seattle, Washington
Australia
Children's Hospital of Westmead, Sydney, New South Wales
Canada
The Hospital for Sick Children, Toronto, Ontario
Italy
C. Besta Neurological Institute, Milan
United Kingdom
National Hospital of Neurology and Neurosurgery, London, England
Dubowitz Neuromuscular Centre, London